ANIXA BIOSCIENCES, INC. Earnings Per Share, Basic and Diluted
ANIXA BIOSCIENCES, INC. (ANIX) reported Earnings Per Share, Basic and Diluted of -$0.13 per share for the 3-month period ending 2022-01-31, per its 10-Q filed 2022-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-11
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2022-01-31 was -$0.13.
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-07-31 was -$0.14.
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-04-30 was -$0.08.
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-01-31 was -$0.09.
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.45.
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.45.
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.59.
- ANIXA BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.79.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-01-31 | -$0.13 10-Q · filed 2022-03-11 | ||||||
| 2021-10-31 | -$0.45 10-K · filed 2022-01-04 | ||||||
| 2021-07-31 | -$0.14 10-Q · filed 2021-09-01 | -$0.32 10-Q · filed 2021-09-01 | |||||
| 2021-04-30 | -$0.08 10-Q · filed 2021-06-10 | -$0.17 10-Q · filed 2021-06-10 | |||||
| 2021-01-31 | -$0.09 10-Q · filed 2022-03-11 | ||||||
| 2020-10-31 | -$0.45 10-K · filed 2022-01-04 | ||||||
| 2020-07-31 | -$0.11 10-Q · filed 2021-09-01 | -$0.36 10-Q · filed 2021-09-01 | |||||
| 2020-04-30 | -$0.12 10-Q · filed 2021-06-10 | -$0.25 10-Q · filed 2021-06-10 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-06-10 | -$0.46 derived: net income ÷ weighted average shares · filed 2021-06-10 | |||
| 2020-01-31 | -$0.13 10-Q · filed 2021-03-11 | -$0.23 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$0.34 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$0.46 derived: net income ÷ weighted average shares · filed 2021-03-11 | |||
| 2019-10-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-01-07 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-01-07 | -$0.34 derived: net income ÷ weighted average shares · filed 2021-01-07 | -$0.59 10-K · filed 2021-01-07 | |||
| 2019-07-31 | -$0.11 10-Q · filed 2020-09-08 | -$0.24 derived: net income ÷ weighted average shares · filed 2020-09-08 | -$0.49 10-Q · filed 2020-09-08 | -$0.77 derived: net income ÷ weighted average shares · filed 2020-09-08 | |||
| 2019-04-30 | -$0.13 10-Q · filed 2020-06-09 | -$0.38 10-Q · filed 2020-06-09 | -$0.66 derived: net income ÷ weighted average shares · filed 2020-06-09 | -$0.96 derived: net income ÷ weighted average shares · filed 2020-06-09 | |||
| 2019-01-31 | -$0.25 10-Q · filed 2020-03-09 | -$0.54 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.83 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.93 derived: net income ÷ weighted average shares · filed 2020-03-09 | |||
| 2018-10-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2020-01-09 | -$0.58 derived: net income ÷ weighted average shares · filed 2020-01-09 | -$0.68 derived: net income ÷ weighted average shares · filed 2020-01-09 | -$0.79 10-K · filed 2020-01-09 | |||
| 2018-07-31 | -$0.30 10-Q · filed 2019-09-06 | -$0.39 derived: net income ÷ weighted average shares · filed 2019-09-06 | -$0.50 10-Q · filed 2019-09-06 | -$0.62 derived: net income ÷ weighted average shares · filed 2019-09-06 | |||
| 2018-04-30 | -$0.08 10-Q · filed 2019-06-12 | -$0.19 10-Q · filed 2019-06-12 | -$0.31 derived: net income ÷ weighted average shares · filed 2019-06-12 | -$0.43 derived: net income ÷ weighted average shares · filed 2019-06-12 | |||
| 2018-01-31 | -$0.11 10-Q · filed 2019-03-13 | -$0.22 derived: net income ÷ weighted average shares · filed 2019-03-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2019-03-13 | -$0.37 derived: net income ÷ weighted average shares · filed 2019-03-13 | |||
| 2017-10-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2019-01-11 | -$0.24 derived: net income ÷ weighted average shares · filed 2019-01-11 | -$0.26 derived: net income ÷ weighted average shares · filed 2019-01-11 | -$0.58 10-K · filed 2019-01-11 | |||
| 2017-07-31 | -$0.12 10-Q · filed 2018-09-07 | -$0.13 derived: net income ÷ weighted average shares · filed 2018-09-07 | -$0.47 10-Q · filed 2018-09-07 | ||||
| 2017-04-30 | $0.02 derived: net income ÷ weighted average shares · filed 2018-06-11 | -$0.37 10-Q · filed 2018-06-11 | |||||
| 2017-01-31 | -$0.41 10-Q · filed 2018-03-09 | ||||||
| 2016-10-31 | -$0.57 10-K · filed 2018-01-09 | ||||||
| 2016-07-31 | -$0.13 10-Q · filed 2017-09-08 | -$0.45 10-Q · filed 2017-09-08 | |||||
| 2016-04-30 | -$0.15 10-Q · filed 2016-05-20 | -$0.33 10-Q · filed 2017-05-26 | |||||
| 2016-01-31 | -$0.18 10-Q · filed 2017-03-16 | ||||||
| 2015-10-31 | -$16.00 10-K · filed 2016-12-08 | -$0.16 10-K · filed 2015-12-23 | |||||
| 2015-07-31 | -$0.18 10-Q · filed 2016-08-19 | -$0.01 10-Q · filed 2016-08-19 | |||||
| 2015-04-30 | -$0.26 10-Q · filed 2016-05-20 | -$0.01 10-Q · filed 2015-05-22 | |||||
| 2014-10-31 | -$1.10 10-K · filed 2015-12-23 | -$0.04 10-K · filed 2015-01-29 | |||||
| 2014-07-31 | $0.00 10-Q · filed 2014-09-15 | -$0.75 10-Q · filed 2015-08-18 | -$0.03 10-Q · filed 2014-09-15 | ||||
| 2014-04-30 | -$0.02 10-Q · filed 2015-05-22 | -$0.03 10-Q · filed 2014-06-16 | |||||
| 2014-01-31 | -$0.02 10-Q · filed 2014-03-17 | ||||||
| 2013-10-31 | -$0.05 10-K · filed 2015-01-29 | ||||||
| 2013-07-31 | -$0.01 10-Q · filed 2014-09-15 | -$0.04 10-Q · filed 2014-09-15 | |||||
| 2013-04-30 | -$0.01 10-Q · filed 2014-06-16 | -$0.02 10-Q · filed 2014-06-16 | |||||
| 2013-01-31 | -$0.01 10-Q · filed 2014-03-17 | ||||||
| 2012-10-31 | -$0.01 10-K · filed 2013-01-29 | -$0.02 10-K/A · filed 2014-01-17 | |||||
| 2012-07-31 | $0.00 10-Q/A · filed 2013-09-20 | -$0.01 10-Q/A · filed 2013-09-20 | |||||
| 2012-04-30 | $0.00 10-Q/A · filed 2013-06-19 | -$0.01 10-Q/A · filed 2013-06-19 | |||||
| 2012-01-31 | $0.00 10-Q/A · filed 2013-03-25 | ||||||
| 2011-10-31 | -$0.02 10-K · filed 2013-01-29 | -$0.04 10-K · filed 2013-01-29 | |||||
| 2011-07-31 | -$0.01 10-K · filed 2013-01-29 | -$0.03 10-Q · filed 2012-09-14 | |||||
| 2011-04-30 | -$0.01 10-K · filed 2013-01-29 | -$0.02 10-Q · filed 2012-06-14 | |||||
| 2011-01-31 | -$0.01 10-K · filed 2013-01-29 | ||||||
| 2010-10-31 | -$0.03 10-K · filed 2012-01-30 | ||||||
| 2010-07-31 | -$0.01 10-Q/A · filed 2011-10-14 | -$0.03 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |